Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Eppendorf PlateReader AF2200

Published: Friday, June 21, 2013
Last Updated: Friday, June 21, 2013
Bookmark and Share
New PlateReader simplifies set-up and analysis for UV/Vis and fluorescence measurements.

The new Eppendorf PlateReader AF2200 is a highly user-friendly device for quantifying biomolecules, such as nucleic acids and proteins, and for measuring fluorescence-based assays in plate format and is designed to simplify both set-up procedures and data analysis.

The AF2200’s convenient hardware and software solutions are engineered for ease-of-use and include integrated temperature control and plate-shaking options, as well as pre-programmed methods including data analysis and factor-based calculation.

By supporting the instrument with smart accessories, such as the Eppendorf µPlate G0.5 for microvolume applications and pre-configurated filter slides, Eppendorf delivers a complete solution for life scientists across many applications.

It is especially valuable where analysis is in the UV/Vis range and/or involves a wide range of fluorescence dyes.

“The software of the PlateReader AF2200 provides the user with pre-programmed applications and a flexible selection of individual parameters,” says Dr Tanja Musiol, Global Product Manager Detection at Eppendorf AG.

Dr Musiol continued, “It also offers the option to freely program all parameters in order to meet individual requirements. Our pre-configured filter slides are optimized to the pre-programmed methods and are designed to offer the highest flexibility while preventing cross talk. The whole system is developed to simplify set-up procedures and data analysis - making daily lab work easier.”

The broad range of accessories that accompanies the PlateReader AF2200 includes pre-configured filter slides with optimized filter assignment.

A choice of 70 additional filters is also available to enable users to tailor measurements for highly specific applications.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Four Gut Bacteria Decrease Asthma Risk in Infants
New research by scientists at UBC and BC Children’s Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos